Share-based Payment Arrangement, Expense of Maze Therapeutics, Inc. from 31 Mar 2024 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Maze Therapeutics, Inc. quarterly Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2024 to 30 Sep 2025.
  • Maze Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $3,864,000, a 65% increase year-over-year.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)

Maze Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,864,000 +$1,521,000 +65% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $3,237,000 +$1,095,000 +51% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $3,226,000 +$916,000 +40% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q3 2024 $2,343,000 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $2,142,000 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $2,310,000 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.